Objectives Esophagogastroduodenoscopy (EGD) is considered a very effective method to
identify gastric cancer (GC). However, the existence of missed lesions has been frequently …

Background & Aims Single-center studies have estimated that 4.6% to 25.8% of gastric
cancers are missed at endoscopy. We performed a population-based study to make a more …

Background A significant proportion of upper gastrointestinal cancers (UGICs) remain
undetected during esophagogastroduodenoscopy (EGD). We investigated the …

AIM: To investigate the causes of missed diagnosis of early gastric cancer (EGC) or high-
grade intraepithelial neoplasia (HGIN) in Chongqing, China. METHODS: The present study …

Objectives Some gastric cancers are missed during diagnostic gastroscopy, but data are
sparse on the clinical characteristics of patients with missed gastric cancers and on the …

Background and study aims: Upper gastrointestinal (UGI) cancer in the Western world
usually presents at an advanced stage, when opportunities for curative therapy are limited …

OBJECTIVES: Little is known about missed rates of upper gastrointestinal cancer (UGC) in
Western populations, with most data originating from Japanese centers quoting high missed …

Background Missed oesophageal cancer (MEC) at upper gastrointestinal endoscopy (UGE)
is poorly documented. Objective The objectives of this study were:(1) to assess the rate …

BACKGROUND: Accurate detection of synchronous multifocal gastric cancer is mandatory
for the successful management of stomach cancer. OBJECTIVE: We compared the …

Background & aims Ten percent of patients with an upper gastrointestinal cancer will have
received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed …